34.72M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.

Similar securities

Based on sector and market capitalization

Report issue